English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  Characterization of a new molecule capable of inhibiting several steps of the amyloid cascade in Alzheimer's disease

Peters, C., Bascunan, D., Burgos, C. F., Bobadilla, C., Gonzalez-Sanmiguel, J., Boopathi, S., et al. (2020). Characterization of a new molecule capable of inhibiting several steps of the amyloid cascade in Alzheimer's disease. Neurobiology of Disease, 141: 104938. doi:10.1016/j.nbd.2020.104938.

Item is

Basic

show hide
Genre: Journal Article

Files

show Files
hide Files
:
1-s2.0-S0969996120302138-main.pdf (Publisher version), 4MB
Name:
1-s2.0-S0969996120302138-main.pdf
Description:
-
OA-Status:
Visibility:
Public
MIME-Type / Checksum:
application/pdf / [MD5]
Technical Metadata:
Copyright Date:
-
Copyright Info:
open access article
:
ScienceDirect_files_29Jul2020_14-18-35.232.zip (Supplementary material), 3MB
Name:
ScienceDirect_files_29Jul2020_14-18-35.232.zip
Description:
-
OA-Status:
Visibility:
Public
MIME-Type / Checksum:
application/zip / [MD5]
Technical Metadata:
Copyright Date:
-
Copyright Info:
-
License:
-

Locators

show

Creators

show
hide
 Creators:
Peters, Christian1, Author           
Bascunan, Denisse, Author
Burgos, Carlos F., Author
Bobadilla, Catalina, Author
Gonzalez-Sanmiguel, Juliana, Author
Boopathi, Subramanian, Author
Riffo, Nicolas, Author
Fernandez-Perez, Eduardo J., Author
Elena Tarnok, Maria, Author
Felipe Aguilar, Luis, Author
Gonzalez, Wendy, Author
Aguayo, Luis G., Author
Affiliations:
1Department: Molecules-Signaling-Development / Klein, MPI of Neurobiology, Max Planck Society, ou_1113546              

Content

show
hide
Free keywords: SOLUBLE OLIGOMERS; BETA OLIGOMERS; RECEPTOR; NEUROTRANSMISSION; SOLUBILITY; MODULATION; TOXICITYAlzheimer; Small molecule; Novel; Multi-step; Drug; Therapy;
 Abstract: Introduction: Alzheimer's disease (AD) is the most prevalent neurodegenerative disorder in elderly people. Existent therapies are directed at alleviating some symptoms, but are not effective in altering the course of the disease. Methods: Based on our previous study that showed that an Fiji-interacting small peptide protected against the toxic effects of amyloid-beta peptide (A beta), we carried out an array of in silico, in vitro, and in vivo assays to identify a molecule having neuroprotective properties. Results: In silico studies showed that the molecule, referred to as M30 (2-Octahydroisoquinolin-2(1H)-ylethanamine), was able to interact with the A beta peptide. Additionally, in vitro assays showed that M30 blocked A beta aggregation, association to the plasma membrane, synaptotoxicity, intracellular calcium, and cellular toxicity, while in vivo experiments demonstrated that M30 induced a neuroprotective effect by decreasing the toxicity of A beta in the dentate gyrus of the hippocampus and improving the alteration in spatial memory in behavior assays. Discussion Therefore, we propose that this new small molecule could be a useful candidate for the additional development of a treatment against AD since it appears to block multiple steps in the amyloid cascade. Overall, since there are no drugs that effectively block the progression of AD, this approach represents an innovative strategy. Significance: Currently, there is no effective treatment for AD and the expectations to develop an effective therapy are low. Using in silico, in vitro, and in vivo experiments, we identified a new compound that is able to inhibit A beta-induced neurotoxicity, specifically aggregation, association to neurons, synaptic toxicity, calcium dyshomeostasis and memory impairment induced by A beta. Because A beta toxicity is central to AD progression, the inhibition mediated by this new molecule might be useful as a therapeutic tool.

Details

show
hide
Language(s): eng - English
 Dates: 2020-07-01
 Publication Status: Published in print
 Pages: 12
 Publishing info: -
 Table of Contents: -
 Rev. Type: Peer
 Identifiers: ISI: 000542971000014
DOI: 10.1016/j.nbd.2020.104938
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Neurobiology of Disease
  Other : Neurobiol. Dis.
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: Oxford : Academic Press
Pages: - Volume / Issue: 141 Sequence Number: 104938 Start / End Page: - Identifier: ISSN: 0969-9961
CoNE: https://pure.mpg.de/cone/journals/resource/954922649144